This Story is Archived
Neosil Announces Positive Phase 2 Data for Androgenetic Alopecia »
Posted by: stephend 1 year, 9 months agoNeosil, Inc., a privately held dermatology-focused pharmaceutical company, today announced positive Phase 2a clinical data demonstrating that its lead product, NEOSH101, increased hair growth significantly in men diagnosed with androgenetic alopecia, also known as pattern hair loss (PHL).
Read Full Story at marketwire.com »
This Story is Archived and Commenting is Closed
Comments: 0
All 0 comments are shown.
Got a Story?
